Real-world analysis of more than 294,000 U.S. Veterans aged 65 and older found mNEXSPIKE was associated with a 35.9% ...
Key TakeawaysModerna shares jumped 8% after its myeloma therapy, mRNA-2808, showed four confirmed responses among 11 heavily pretreated patients. The data shows Moderna’s mRNA can get the body to make ...
SA Spotlight uses AI to summarize content published on Seeking Alpha. All summaries are reviewed by human editors prior to publication. Moderna (MRNA) shares tumbled about 17% on Thursday after leaked ...
Six melanoma specialists said the Moderna and Merck vaccine results represent a clinically meaningful advance in melanoma treatment.
Moderna released full data on its closely watched cancer vaccine developed with Merck.